1-6 of 6
Peter Altevogt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B42: The cell adhesion molecule, L1CAM, is important for the dissemination and metastasis of fallopian tube precursor lesions

Kai Doberstein, Marcin Iwanicki, Mina Fogel, Peter Altevogt, Ronny Drapkin
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): B42.
https://doi.org/10.1158/1557-3265.OVCA17-B42
Published: 01 August 2018
View article titled, Abstract B42: The cell adhesion molecule, L1CAM, is important for the dissemination and metastasis of fallopian tube precursor lesions
Journal Articles

Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions

Matthias Piesche, Vincent T. Ho, Haesook Kim, Yukoh Nakazaki, Michael Nehil, Nasser K. Yaghi, Dmitriy Kolodin, Jeremy Weiser, Peter Altevogt, Helena Kiefel, Edwin P. Alyea, Joseph H. Antin, Corey Cutler, John Koreth, Christine Canning, Jerome Ritz, Robert J. Soiffer, Glenn Dranoff
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1010–1018.
https://doi.org/10.1158/1078-0432.CCR-14-1956
Published: 01 March 2015
View article titled, Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
Open the PDF for Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions in another window
Includes: Supplementary data
Journal Articles

Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis

Karin Knogler, Jürgen Grünberg, Kurt Zimmermann, Susan Cohrs, Michael Honer, Simon Ametamey, Peter Altevogt, Mina Fogel, P. August Schubiger, Ilse Novak-Hofer
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 603–611.
https://doi.org/10.1158/1078-0432.CCR-06-1486
Published: 25 January 2007
View article titled, Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis
Open the PDF for Copper-67 Radioimmunotherapy and Growth Inhibition by Anti–L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis in another window
Journal Articles

Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival

Wilko Weichert, Carsten Denkert, Mick Burkhardt, Tserenchunt Gansukh, Joachim Bellach, Peter Altevogt, Manfred Dietel, Glen Kristiansen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6574–6581.
https://doi.org/10.1158/1078-0432.CCR-05-0606
Published: 15 September 2005
View article titled, Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival
Open the PDF for Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival in another window
Journal Articles

Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells

Paul Gutwein, Alexander Stoeck, Svenja Riedle, Daniela Gast, Steffen Runz, Thomas P. Condon, Alexander Marmé, Minh-Chau Phong, Otwin Linderkamp, Alexander Skorokhod, Peter Altevogt
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2492–2501.
https://doi.org/10.1158/1078-0432.CCR-04-1688
Published: 06 April 2005
View article titled, Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells
Open the PDF for Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells in another window
Journal Articles

CD24 Expression Is a New Prognostic Marker in Breast Cancer

Glen Kristiansen, Klaus-Jürgen Winzer, Empar Mayordomo, Joachim Bellach, Karsten Schlüns, Carsten Denkert, Edgar Dahl, Christian Pilarsky, Peter Altevogt, Hans Guski, Manfred Dietel
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (13): 4906–4913.
Published: 27 October 2003
View article titled, CD24 Expression Is a New Prognostic Marker in Breast Cancer
Open the PDF for CD24 Expression Is a New Prognostic Marker in Breast Cancer in another window